{"schema_version":"secwatch.filing_event.v1","accession":"0000010795-22-000059","form_type":"8-K","ticker":"BDX","cik":"0000010795","company_name":"BECTON DICKINSON & CO","filed_at":"2022-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.909313+00:00","generated_at":"2026-06-23T21:14:31.873079+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BD appoints Garrison as Medical segment president and Byrd as Interventional segment president; Campion departs","bullets":["Michael Garrison named EVP & President, Medical segment, effective Sept 6, 2022; previously led Medication Management Solutions.","Richard Byrd named EVP & President, Interventional segment, effective Sept 6, 2022; previously led Medication Delivery Solutions.","Simon Campion to depart BD on Sept 9, 2022 for executive role elsewhere; he joined via C.R. Bard acquisition.","Both Garrison and Byrd report to CEO Tom Polen and join Executive Leadership Team."],"urls":{"canonical":"https://secwatch.observer/filing/0000010795-22-000059","json":"https://secwatch.observer/filing/0000010795-22-000059.json","markdown":"https://secwatch.observer/filing/0000010795-22-000059.md","text":"https://secwatch.observer/filing/0000010795-22-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/0000010795-22-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/bdx-20220822.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:14:31.873079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"09dca2170f","claim":"Michael Garrison was named as Executive Vice President and President, Medical Segment at BECTON DICKINSON & CO.","evidence_excerpt":"Michael Garrison has been named BD's Executive Vice President and President, Medical Segment","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/0000010795-22-000059-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"named"},{"label":"Role","value":"Executive Vice President and President, Medical Segment"}],"fact_type":"executive_change"},{"claim_id":"8111e80f79","claim":"Richard Byrd was named as Executive Vice President and President, Interventional Segment at BECTON DICKINSON & CO.","evidence_excerpt":"Richard Byrd has been named BD's Executive Vice President and President, Interventional Segment","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/0000010795-22-000059-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"named"},{"label":"Role","value":"Executive Vice President and President, Interventional Segment"}],"fact_type":"executive_change"},{"claim_id":"8997396b90","claim":"Simon Campion departed as Executive Vice President and President, Medical Segment at BECTON DICKINSON & CO.","evidence_excerpt":"Simon Campion informed BD that he will depart BD on September 9, 2022 for an executive role in the health care industry.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/10795/000001079522000059/0000010795-22-000059-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Executive Vice President and President, Medical Segment"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}